Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

24.0%

6 terminated/withdrawn out of 25 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

16%

4 trials in Phase 3/4

Results Transparency

11%

2 of 18 completed trials have results

Key Signals

2 with results5 withdrawn

Enrollment Performance

Analytics

Phase 4

3(50.0%)

Phase 2

1(16.7%)

Phase 3

1(16.7%)

N/A

1(16.7%)

6Total

Phase 4(3)

Phase 2(1)

Phase 3(1)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (25)

Showing 20 of 25 trials

NCT01294228Completed

Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU

Role: lead

NCT00206830Phase 2Completed

SHORTness of Breath In the Emergency Department (SHORTIE)

Role: lead

NCT00206843Not ApplicableCompleted

Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT II)

Role: lead

NCT00206908Completed

BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)

Role: lead

NCT00933764Withdrawn

Clinical Performance Evaluation of the Cholestech LDX Cardiac hsCRP Test (CLEAR)

Role: lead

NCT00472628Withdrawn

Multi-marker INDex for the Risk Assessment of Sepsis in the Emergency departmenT (MINDSET)

Role: lead

NCT00951795Withdrawn

Accuracy of the Pima™ CD4 Test for Enumeration of CD4+ T-Cell Counts

Role: lead

NCT00206817Phase 4Withdrawn

Rapid Assessment of Cardiac Markers for the Evaluation of Acute Coronary Syndrome (RACE-ACS)

Role: lead

NCT00907231Withdrawn

Evaluation of Serial Troponin and Cardiac Multimarkers at the Point of Care in the Emergency Department

Role: lead

NCT00874289Completed

Utility of Neutrophil Gelatinase-associated Lipocalin (NGAL) in Predicting Renal Impairment, Further Decompensation and Rehospitalization in Acutely Decompensated and Chronic Heart Failure Patients

Role: collaborator

NCT00206856Phase 4Terminated

Rapid Assessment of Bedside BNP In Treatment of Heart Failure (RABBIT)

Role: lead

NCT01036646Completed

User Performance Evaluation of the INRatio® Prothrombin Time (PT) Monitoring System With a New INRatio Test Strip Designed for Low Sample Volume and Heparin Insensitivity

Role: lead

NCT01037270Completed

Evaluation of the Accuracy and Precision of the INRatio® Prothrombin Time (PT) Monitoring System With New INRatio Test Strip Designed for Low Sample Volume and Heparin Insensitivity

Role: lead

NCT01134913Completed

Multi-Markers In the Diagnosis of Acute Coronary Syndrome

Role: lead

NCT00946231Completed

Heart Failure (HF) Assessment With B-type Natriuretic Peptide (BNP) In The Home

Role: lead

NCT00424762Phase 4Completed

Effect of Rosiglitazone Versus Placebo on Cardiovascular Performance and Myocardial Triglyceride

Role: collaborator

NCT00933738Completed

Evaluation of the Accuracy of the INRatio Prothrombin Time (PT) Monitoring System With a New Test Strip for the Oral Anticoagulation Therapy Patient in the Presence of Heparin and Low Molecular Weight Heparin (e.g., Enoxaparin or Dalteparin)

Role: lead

NCT00845741Completed

Neutrophil Gelatinase-associated Lipocalin (NGAL) Evaluation in Emergency Department (ED) All-Comers

Role: lead

NCT00693745Completed

Neutrophil Gelatinase-Associated Lipcalin (NGAL) Evaluation Along With B-Type Natriuretic Peptide in Acutely Decompensated HF

Role: lead

NCT00416013Unknown

Correlations Between BNP & Dry Weight, and Between Troponin & Mortality, in Hemodialysis Patients

Role: collaborator